LIST OF TABLES

TABLE 01.GLOBAL VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 02.RECOMBINANT & CONJUGATE VACCINE MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 03.INACTIVATED VACCINE, BY REGION, 2019-2027 ($MILLION)
TABLE 04.LIVE ATTENUATED VACCINE, BY REGION, 2019-2027 ($MILLION)
TABLE 05.TOXOID VACCINE, BY REGION, 2019-2027 ($MILLION)
TABLE 06.VACCINE MARKET FOR OTHER VACCINES, BY REGION, 2019-2027 ($MILLION)
TABLE 07.GLOBAL VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 08.VACCINE MARKET FOR PNEUMOCOCCAL DISEASE, BY REGION, 2019-2027 ($MILLION)
TABLE 09.VACCINE MARKET FOR INFLUENZA, BY REGION, 2019-2027 ($MILLION)
TABLE 10.VACCINE MARKET FOR HUMAN PAPILLOMA VIRUS, BY REGION, 2019-2027 ($MILLION)
TABLE 11.VACCINE MARKET FOR MENINGOCOCCAL DISEASE, BY REGION, 2019-2027 ($MILLION)
TABLE 12.VACCINE MARKET FOR ROTAVIRUS DISEASE, BY REGION, 2019-2027 ($MILLION)
TABLE 13.VACCINE MARKET FOR VARICELLA, MEASLES, MUMPS, AND RUBELLA (MMR), BY REGION, 2019-2027 ($MILLION)
TABLE 14.VACCINE MARKET FOR DIPHTHERIA, PERTUSSIS, & TETANUS, BY REGION, 2019-2027 ($MILLION)
TABLE 15.VACCINE MARKET FOR POLIO, BY REGION, 2019-2027 ($MILLION)
TABLE 16.VACCINE MARKET FOR HEPATITIS, BY REGION, 2019-2027 ($MILLION)
TABLE 17.VACCINE MARKET FOROTHER INDICATION, BY REGION, 2019-2027 ($MILLION)
TABLE 18.GLOBAL VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 19.VACCINE MARKET FOR PEDIATRIC, BY REGION, 2019-2027 ($MILLION)
TABLE 20.VACCINE MARKET FOR ADULTS VACCINES, BY REGION, 2019-2027 ($MILLION)
TABLE 21.VACCINE MARKET FOR TRAVELERS VACCINES, BY REGION, 2019-2027 ($MILLION)
TABLE 22.VACCINE MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 23.NORTH AMERICA VACCINE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 24.NORTH AMERICA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 25.NORTH AMERICA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 26.NORTH AMERICA MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 27.U.S. VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 28.U.S. VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 29.U.S. VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 30.MEXICO VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 31.MEXICO VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 32.MEXICO VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 33.CANADA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 34.CANADA VACCINE MARKET, BY INDICATION , 2019-2027 ($MILLION)
TABLE 35.CANADA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 36.EUROPE VACCINE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 37.EUROPE VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 38.EUROPE VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 39.EUROPE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 40.GERMANY VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 41.GERMANY VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 42.GERMANY VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 43.FRANCE VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 44.FRANCE VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 45.FRANCE VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 46.UK VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 47.UK VACCINE MARKET, BY INDICATION , 2019-2027 ($MILLION)
TABLE 48.UK VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 49.ITALY VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 50.ITALY VACCINE MARKET, BY INDICATION , 2019-2027 ($MILLION)
TABLE 51.ITALY VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 52.SPAIN VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 53.SPAIN VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 54.SPAIN VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 55.REST OF EUROPE VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 56.REST OF EUROPE VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 57.REST OF EUROPE VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 58.ASIA-PACIFIC VACCINE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 59.ASIA-PACIFIC VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 60.ASIA-PACIFIC VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 61.ASIA-PACIFIC MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 62.JAPAN VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 63.JAPAN VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 64.JAPAN VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 65.CHINA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 66.CHINA VACCINE MARKET, BY INDICATION , 2019-2027 ($MILLION)
TABLE 67.CHINA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 68.INDIA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 69.INDIA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 70.INDIA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 71.AUSTRALIA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 72.AUSTRALIA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 73.AUSTRALIA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 77.LAMEA VACCINE MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 78.LAMEA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 79.LAMEA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 80.LAMEA MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 81.BRAZIL VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 82.BRAZIL VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 83.BRAZIL VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 84.SAUDI ARABIA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 85.SAUDI ARABIA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 86.SAUDI ARABIA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 87.SOUTH AFRICA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 88.SOUTH AFRICA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 89.SOUTH AFRICA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 90.REST OF LAMEA VACCINE MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 91.REST OF LAMEA VACCINE MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 92.REST OF LAMEA VACCINE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 93.ASTRAZENECA: COMPANY SNAPSHOT
TABLE 94.ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 95.CSL: COMPANY SNAPSHOT
TABLE 96.CSL: OPERATING SEGMENTS
TABLE 97.CSL: PRODUCT PORTFOLIO
TABLE 98.EMERGENT SOLUTIONS: COMPANY SNAPSHOT
TABLE 99.EMERGENT SOLUTIONS: OPERATING SEGMENTS
TABLE 100.EMERGENT SOLUTIONS: PRODUCT PORTFOLIO
TABLE 101.GSK: COMPANY SNAPSHOT
TABLE 102.GSK: OPERATING SEGMENTS
TABLE 103.GSK: PRODUCT PORTFOLIO
TABLE 104.J&J: COMPANY SNAPSHOT
TABLE 105.J&J: OPERATING SEGMENTS
TABLE 106.J&J: PRODUCT PORTFOLIO
TABLE 107.MERCK: COMPANY SNAPSHOT
TABLE 108.MERCK: OPERATING SEGMENTS
TABLE 109.MERCK: PRODUCT PORTFOLIO
TABLE 110.NOVAVAX: COMPANY SNAPSHOT
TABLE 111.NOVAVAX: PRODUCT PORTFOLIO:
TABLE 112.PFIZER: COMPANY SNAPSHOT
TABLE 113.PFIZER: OPERATING SEGMENTS
TABLE 114.PFIZER: PRODUCT PORTFOLIO
TABLE 115.SANOFI: COMPANY SNAPSHOT
TABLE 116.SANOFI S.A.: OPERATING SEGMENTS
TABLE 117.SANOFI S.A.: PRODUCT PORTFOLIO
TABLE 118.SERUM INSTITUTE: COMPANY SNAPSHOT
TABLE 119.SERUM INSTITUTE: PRODUCT PORTFOLIO

LIST OF FIGURE

LIST OF FIGURES

FIGURE 01.VACCINE MARKETSEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018-2020*
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
FIGURE 04.TOP WINNING STRATEGIES: COMPANY , 2018-2020
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.TOP INVESTMENT POCKETS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 08.MODERATEBARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.HIGH THREAT OF NEW ENTRANT
FIGURE 12.IMPACT ANALYSIS, VACCINE MARKET
FIGURE 14.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR RECOMBINANT & CONJUGATE VACCINES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR INACTIVATED VACCINE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR LIVE ATTENUATED VACCINES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR TOXOID, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 21.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR PNEUMOCOCCAL DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR INFLUENZA, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR HUMAN PAPILLOMA VIRUS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR MENINGOCOCCAL DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR ROTAVIRUS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 26.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR VARICELLA, MEASLES, MUMPS, & RUBELLA DISEASE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 27.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR DIPHTHERIA, PERTUSSIS, & TETANUS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 28.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR POLIO, BY COUNTRY, 2019 & 2027 (%)
FIGURE 29.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR HEPATITIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 30.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 31.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR PEDIATRIC, BY COUNTRY, 2019 & 2027 (%)
FIGURE 32.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR ADULT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 33.COMPARATIVE ANALYSIS OF VACCINE MARKET FOR TRAVELERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 34.ASTRAZENECA: NET SALES, 2017-2019 ($MILLION)
FIGURE 35.ASTRAZENECA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 36.CSL: NET SALES, 2017-2019 ($MILLION)
FIGURE 37.CSL REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 38.CSL LIMITED: REVENUE SHARE BY REGIONS, 2019 (%)
FIGURE 39.EMERGENT SOLUTIONS: NET SALES, 2017-2019 ($MILLION)
FIGURE 40.EMERGENT SOLUTIONS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.EMERGENT SOLUTIONS: REVENUE SHARE BY REGION, 2019(%)
FIGURE 42.GSK: NET SALES, 2017-2019 ($MILLION)
FIGURE 43.GSK: REVENUE SHARE BY SEGMENT, 2019(%)
FIGURE 44.GSK: REVENUE SHARE BY REGION, 2019(%)
FIGURE 45.J&J: NET SALES, 2017-2019 ($MILLION)
FIGURE 46.J&J: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 47.J&J: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 48.MERCK: NET SALES, 2017-2019 ($MILLION)
FIGURE 49.MERCK: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 50.MERCK: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 51.NOVAVAX: NET SALES, 2017-2019 ($MILLION)
FIGURE 52.PFIZER: NET SALES, 2017-2019 ($MILLION)
FIGURE 53.PFIZER: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 54.PFIZER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 55.SANOFI S.A.: NET SALES, 2017-2019 ($MILLION)
FIGURE 56.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 57.SANOFI: REVENUE SHARE BY REGION, 2019(%)